Stock ABBV ABBVIE INC.
Add to a list
To use this feature you must be a member
Log inSign up

News AbbVie Inc.

Equities

ABBV

US00287Y1091

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-25 pm EDT 		Pre-market 07:18:48 am
167.3 USD -0.30% Intraday chart for AbbVie Inc. 168.6 +0.79%
01:23pm Tech Strength Boosts Wall Street Pre-Bell; Asia, Europe Up MT
01:20pm Stocks Rebound Pre-Bell Ahead of Pending Inflation Report; Asia, Europe Gain MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tech Strength Boosts Wall Street Pre-Bell; Asia, Europe Up
MT
Stocks Rebound Pre-Bell Ahead of Pending Inflation Report; Asia, Europe Gain
MT
North American Morning Briefing : Tech Still in -2-
DJ
Futures climb as Alphabet, Microsoft results lift megacaps
RE
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
RE
AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint
MT
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
PR
AbbVie Inc. Announces Positive Topline Results from Level Up
CI
Scholz promises support for pharma sector in Germany as Merck invests
RE
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX Cosmetic and Their Other Biggest Brands
AQ
US CDC warns of harmful reactions to fake Botox injections
RE
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
PR
Pfizer: new Emblaveo antibiotic approved in the EU
CF
Sector Update: Health Care Stocks Advance Late Afternoon
MT
Sector Update: Health Care Stocks Rise Friday Afternoon
MT
Sector Update: Health Care
MT
Alvotech Shares Rise After Signing Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US
MT
AbbVie - Phase 3 SELECT-GCA Study of Upadacitinib showed Positive Results in Patients with Giant Cell Arteritis
AQ
Deutsche Bank Raises AbbVie's Price Target to $175 Form $170
MT
Alvotech Signs Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABBV Stock
  4. News AbbVie Inc.